MASSDEVICE ON CALL — IBM’s Watson supercomputer, which trounced a pair of human competitors on Jeopardy more than year ago, has begun treating patients at the Memorial Sloan-Kettering Cancer Center.
A result of a partnership announced earlier this year, Watson is "in the trenches" with oncologists to analyze cancer research and literature to provide diagnostic and treatment solutions.
Watson "reads" through millions of pages of medical journals and other clinical research, using its "natural language processing" algorithms to find information relevant to a physician query, InformationWeek reported.
The clinical must make the final decision regarding diagnoses or treatment decisions, but Watson can help by offering some direction.
Sloan-Kettering is now merging its massive oncology database, including information for around 1.2 million patients, with Watson’s processing ability, taking aim initially at treatment and diagnostics for non-small-cell lung cancer.
By the end of this, IBM and Sloan-Kettering hope to have Watson working on real cases, according to the news source.
J&J delays diagnostic and device review in wake of Hurricane Sandy
Healthcare giant Johnson & Johnson (NYSE:JNJ) will postpone its medical device and diagnostics business review, slated originally for November 1, in order to "ensure the safety of its employees and expected attendees in the aftermath of the storm."
The new date will be scheduled sometime in early 2013.
Obese teens may be more likely to develop renal disease
Adolescent obesity may increase the risk of developing renal disease within a 25-year period, as obese teens become obese adults, who are also at greater risk for diabetes, researchers say.
New technology better detects pediatric "lazy eye"
Vision-screening technology may better detects incidence of "lazy eye" in children and other patients who cannot comply with traditional screening with vision charts.
No easy solutions for the high cost of Medicare/Medicaid dual collectors
Existing efforts to reign in the cost of treating patients who receive both Medicare and Medicaid have produced only modest savings at best, according to a Kaiser Family Foundation report.